Toll Brothers ($38.19): Analysts expect the homebuilder to report earnings of 18 cents a share. The stock set its 2014 low at $34.50 on Jan. 27 and last Friday set its 2014 high at $38.50 well above its 200-day SMA at $33.69. The weekly chart is positive but overbought with the five-week MMA at $36.55 and the 200-week SMA at $25.95. The stock has a gain of 10.8% over the last 12 months. Semiannual value levels are $35.68 and $33.48 with a quarterly risky level at $44.60.

Visteon (VC) ($84.70): Analysts expect the provider of climate, electronic and lighting for vehicle manufacturers to earn $1.46 a share. The stock set its all-time intraday high at $88.74 on Jan. 13 then traded as low as $77.72 on Feb. 5 well above its 200-day SMA at $73.07. The weekly chart is neutral with its five-week MMA at $81.99. The stock has a gain of 51.9% over the last 12 months. Semiannual and quarterly value levels are $72.36 and $72.06 with monthly and semiannual risky levels at $86.73 and $93.29.

These two companies report results afterhours Tuesday:

First Solar (FSLR) ($55.93): Analysts expect the maker of thin film semiconductors that lower solar energy costs to earn $1.00 a share. The stock was a momentum traders' delight going into May 2008 setting an all-time high at $317.00. First Solar set its all-time low at $11.43 in June 2012 then traded to a multiyear intraday high at $65.99 on Nov. 14, 2013. The stock's 2014 low was set at $47.04 on Feb. 5 which was temporarily below its 200-day SMA at $49.18. Last week the stock traded as high as $57.95. The weekly chart is positive with its five-week MMA at $53.07 and its 200-week SMA at $70.71 which could be challenged on a positive reaction to earnings. The stock has a gain of 62.5% over the last 12 months. I show weekly and monthly value levels at $50.23 and $42.69.

Boston Beer (SAM) ($229.07): Analysts expect the craft brewery and cider products maker to earn $1.51 a share. The stock set an all-time intraday high at $265.53 on Oct. 22 then traded to a 2014 low at $202.78 on Feb. 5 which was temporarily below its 200-day SMA now at $210.37. The weekly chart is positive with its five-week MMA at $222.61 and its 200-week SMA at $122.36. The stock has a gain of 52.8% over the last 12 months. Semiannual and annual value levels are $209.36 and $190.62 with a monthly risky level at $277.93.

At the time of publication the author held no positions in any of the stocks mentioned.

Follow @Suttmeier

This article represents the opinion of a contributor and not necessarily that of TheStreet or its editorial staff

Richard Suttmeier is the chief market strategist at ValuEngine.com. He has been a professional in the U.S. Capital Markets since 1972, transferring his engineering skills to the trading and investment world.

Suttmeier has an engineering degree from Georgia Tech and a Master of Science degree from Brooklyn Poly. He began his career in the financial services industry in 1972 trading U.S. Treasury securities in the primary dealer community. He became the first long bond trader for Bache in 1978, and formed the Government Bond Department at LF Rothschild in 1981, helping establish that firm as a primary dealer in 1986. This experience gives him the insights to be an expert on monetary policy, which he features in his newsletters, and market commentary.

Suttmeier's industry licenses include, Series 7 and Registered Principal (Series 24). He has been the Chief Market Strategist for ValuEngine.com since 2008 and often appears on financial TV.

Click here for details on Suttmeier's "Buy and Trade" investment strategy.

Richard Suttmeier can be reached at RSuttmeier@Gmail.com

If you liked this article you might like

3 'Orphan Stocks' to Consider Adopting

Alaska Air, Corcept Therapeutics, First Solar: 'Mad Money' Lightning Round

Markets Focus on Business: Cramer's 'Mad Money' Recap (Monday 8/28/17 )

First Solar Warms Up

First Solar Awarded 241MW Supply Contract for Edify Energy